Bill J. Smith

Single‐Dose Pharmacokinetics of Varenicline, a Selective Nicotinic Receptor Partial Agonist, in Healthy Smokers and Nonsmokers

Hélène M. Faessel, Bill J. Smith, Megan Gibbs et al. · The Journal of Clinical Pharmacology · 2006 · 104 citations

Pharmacokinetic-Pharmacodynamic Modeling of Biomarker Response and Tumor Growth Inhibition to an Orally Available cMet Kinase Inhibitor in Human Tumor Xenograft Mouse Models

Shinji Yamazaki, Judith Skaptason, David Romero et al. · Drug Metabolism and Disposition · 2008 · 94 citations

Characterization of Differential Tissue Abundance of Major Non-CYP Enzymes in Human

Abdul Basit, Naveen K. Neradugomma, Christopher C. Wolford et al. · Molecular Pharmaceutics · 2020 · 82 citations

Pathology, Redox Biology, Toxicological Mechanism +23

Pharmacokinetic/Pharmacodynamic Modeling of Crizotinib for Anaplastic Lymphoma Kinase Inhibition and Antitumor Efficacy in Human Tumor Xenograft Mouse Models

Shinji Yamazaki, Paolo Vicini, Zhongzhou Shen et al. · Journal of Pharmacology and Experimental Therapeutics · 2011 · 67 citations

Ovarian Toxicity of 4-Vinylcyclohexene and Related Olefins in B6C3F1 Mice: Role of Diepoxides

Julie K. Doerr, Stephen B. Hooser, Bill J. Smith et al. · Chemical Research in Toxicology · 1995 · 64 citations